Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections (Q36470482)

14 August 2017

1 reference

title

Leflunomide: a possible alternative for gangciclovir sensitive and resistant cytomegalovirus infections (English)

1 reference

14 August 2017

0 references

Sudarsanam TD

1

1 reference

14 August 2017

Sahni RD

series ordinal

2

1 reference

14 August 2017

John GT

series ordinal

3

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

Postgraduate Medical Journal

14 August 2017

1 reference

14 August 2017

82

1 reference

14 August 2017

967

1 reference

14 August 2017

313-314

1 reference

Basic and clinical research in polyomavirus nephropathy.

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Dis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infection

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Leflunomide therapy for cytomegalovirus disease in renal allograft recepients

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2563786

Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16679469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cytomegalovirus prophylaxis in solid organ transplant recipients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16679469

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/PGMJ.2005.038521

1 reference

14 August 2017

1 reference

14 August 2017

1 reference